Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Cellerix raises €27.2mm through its Series B round

Executive Summary

Cellerix (cell therapies) has raised €27.2mm ($38.31mm) through the closing of its Series B venture round. LSP and Ventech led the round and were joined by fellow new investors Ysios Capital Partners, Roche Venture Fund, and Novartis Venture Fund as well as current backers Genetrix SL, Grupo A&G, Jose Antonio Matji, and Cellerix management.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Gene Therapy, Cell Therapy
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies